Julian W. Adlard

Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2.

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2.

Journal: Journal of medical genetics

Published: June 07, 2022

Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.

Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 03, 2022

Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service.

Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service.

Journal: British journal of cancer

Published: August 25, 2021

SDHC phaeochromocytoma and paraganglioma: A UK-wide case series.

SDHC phaeochromocytoma and paraganglioma: A UK-wide case series.

Journal: Clinical endocrinology

Published: May 05, 2021

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.

Journal: Journal of the National Cancer Institute

Published: February 16, 2021

Long-read nanopore sequencing enables accurate confirmation of a recurrent PMS2 insertion-deletion variant located in a region of complex genomic architecture.

Long-read nanopore sequencing enables accurate confirmation of a recurrent PMS2 insertion-deletion variant located in a region of complex genomic architecture.

Journal: Cancer genetics

Published: October 21, 2020

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: August 07, 2020

Homozygosity for the pathogenic RET hotspot variant p.Cys634Trp: A consanguineous family with MEN2A.

Homozygosity for the pathogenic RET hotspot variant p.Cys634Trp: A consanguineous family with MEN2A.

Journal: European journal of medical genetics

Published: June 15, 2020

Multiple primary cancers (renal papillary, lymphoma and teratoma) and hepatic cysts in association with a pathogenic germline mutation in the MET gene.

Multiple primary cancers (renal papillary, lymphoma and teratoma) and hepatic cysts in association with a pathogenic germline mutation in the MET gene.

Journal: Familial cancer

Published: April 09, 2020

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.

Journal: American journal of obstetrics and gynecology

Published: April 06, 2020

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.

Journal: Breast cancer research : BCR

Published: February 28, 2020

Prostate Cancer Risk by BRCA2 Genomic Regions.

Prostate Cancer Risk by BRCA2 Genomic Regions.

Journal: European urology

Published: January 28, 2020

Showing 1-12 of 58

Last Updated: 09/26/2026